Keybanc Maintains Overweight on Axonics, Raises Price Target to $71
Portfolio Pulse from richadhand@benzinga.com
Keybanc analyst Matthew Mishan maintains an Overweight rating on Axonics (NASDAQ:AXNX) and raises the price target from $70 to $71.
July 28, 2023 | 8:29 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Axonics' price target has been raised from $70 to $71 by Keybanc, which maintains an Overweight rating on the stock.
The raised price target indicates that the analyst sees potential for the stock's price to increase. This could lead to positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100